AU1218892A - Pharmaceutical aerosol formulations - Google Patents

Pharmaceutical aerosol formulations

Info

Publication number
AU1218892A
AU1218892A AU12188/92A AU1218892A AU1218892A AU 1218892 A AU1218892 A AU 1218892A AU 12188/92 A AU12188/92 A AU 12188/92A AU 1218892 A AU1218892 A AU 1218892A AU 1218892 A AU1218892 A AU 1218892A
Authority
AU
Australia
Prior art keywords
aerosol formulations
pharmaceutical aerosol
pharmaceutical
formulations
aerosol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU12188/92A
Other versions
AU646723B2 (en
Inventor
Kurt Herzog
Manfred Keller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Skyepharma AG
Original Assignee
Ciba Geigy AG
Jago Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Jago Pharma AG filed Critical Ciba Geigy AG
Publication of AU1218892A publication Critical patent/AU1218892A/en
Application granted granted Critical
Publication of AU646723B2 publication Critical patent/AU646723B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU12188/92A 1991-03-14 1992-03-10 Pharmaceutical aerosol formulations Ceased AU646723B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH78191 1991-03-14
CH781/91 1991-03-14

Publications (2)

Publication Number Publication Date
AU1218892A true AU1218892A (en) 1992-09-17
AU646723B2 AU646723B2 (en) 1994-03-03

Family

ID=4195038

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12188/92A Ceased AU646723B2 (en) 1991-03-14 1992-03-10 Pharmaceutical aerosol formulations

Country Status (13)

Country Link
EP (1) EP0504112A3 (en)
JP (1) JPH04327527A (en)
KR (1) KR920017643A (en)
AU (1) AU646723B2 (en)
CA (1) CA2062854A1 (en)
FI (1) FI921060A (en)
HU (1) HU208398B (en)
IE (1) IE920826A1 (en)
IL (1) IL101169A0 (en)
MX (1) MX9201082A (en)
NO (1) NO920987L (en)
NZ (1) NZ241938A (en)
ZA (1) ZA921877B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU680967B2 (en) * 1993-12-20 1997-08-14 Minnesota Mining And Manufacturing Company Flunisolide aerosol formulations

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4003270A1 (en) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg NEW SPEED GASES AND THEIR USE IN MEDICINE PREPARATIONS
MX9203481A (en) 1990-10-18 1992-07-01 Minnesota Mining & Mfg FORMULATIONS.
EP0587790B2 (en) 1991-06-10 2000-03-08 Schering Corporation Non-chlorofluorocarbon aerosol formulations
DE4123663A1 (en) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Medicinal aerosol free from fluoro:chlorocarbon(s) - contains active agent in suspending or dispersing aid and alcohol with hepta:fluoro:propane as propellant
DE4132176C2 (en) * 1991-09-27 1997-03-13 Ig Spruehtechnik Gmbh Metered aerosols with isobutane as propellant
EP0616525B1 (en) * 1991-12-12 1995-09-27 Glaxo Group Limited Pharmaceutical aerosol formulation
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
CA2381329C (en) 1991-12-12 2003-04-15 Glaxo Group Limited Medicaments
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
DE69233319T2 (en) 1991-12-18 2005-02-17 Minnesota Mining & Manufacturing Company, St. Paul Aerosol compositions for drug suspensions
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
DE59206234D1 (en) * 1991-12-31 1996-06-13 Hoechst Ag Medical aerosol formulation
RU2126248C1 (en) * 1992-12-09 1999-02-20 Берингер Ингельхейм Фармасьютикалз, Инк. Liquid pharmaceutical composition as an aerosol
DE69420401T2 (en) * 1993-03-29 2000-05-04 Lynchris Pharmaceuticals, Ltd. AEROSOL-BASED ANESTHETIC BASED ON LIDOCAIN
US5593661A (en) * 1993-03-29 1997-01-14 Henry; Richard A. Lidocaine aerosol anaesthetic
DE4323636A1 (en) * 1993-07-15 1995-01-19 Hoechst Ag Pharmaceutical preparations from coated, poorly water-soluble pharmaceutical substances for inhalation pharmaceutical forms and processes for their preparation
US5837699A (en) * 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
KR970701535A (en) * 1994-03-14 1997-04-12 지울리아노 페트렐리 Aerosol drug formulations containing vitamin'E
HUP9800641A3 (en) 1995-04-14 2001-04-28 Glaxo Wellcome Inc Res Triangl Metered dose inhaler for beclomethasone dipropionate
JPH11503352A (en) 1995-04-14 1999-03-26 グラクソ、ウェルカム、インコーポレーテッド Metered dose inhaler for fluticasone propionate
ATE297773T1 (en) * 1995-04-14 2005-07-15 Smithkline Beecham Corp DOSAGE INHALER FOR SALMETEROL
EE03997B1 (en) * 1995-04-14 2003-04-15 Glaxo Wellcome Inc. Albuterol metered dose inhaler
CA2225601C (en) 1995-06-27 2003-10-14 Boehringer Ingelheim Kg New stable pharmaceutical preparation for producing propellant-free aerosols
GB9526392D0 (en) 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
US6054488A (en) * 1996-06-11 2000-04-25 3M Innovative Properties Company Medicinal aerosol formulations of formoterol
GB9620187D0 (en) † 1996-09-27 1996-11-13 Minnesota Mining & Mfg Medicinal aerosol formulations
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
CA2280099C (en) 1997-02-05 2005-12-27 Jago Pharma Ag Medical aerosol formulations
AU6823098A (en) * 1997-02-28 1998-09-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistic combination of pde inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20030077227A1 (en) 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20030185761A1 (en) 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
EP1036561A1 (en) * 1997-10-01 2000-09-20 Flemington Pharmaceutical Corporation Buccal, non-polar spray
US20040136914A1 (en) 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
AU1594099A (en) * 1997-11-18 1999-06-07 Allied-Signal Inc. Hydrofluorocarbon refrigerants
GB9807232D0 (en) 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
ES2234266T3 (en) 1998-07-24 2005-06-16 Jago Research Ag MEDICAL FORMULATIONS FOR AEROSOLS.
DE59904648D1 (en) 1998-08-04 2003-04-24 Jago Res Ag Muttenz MEDICAL AEROSOL FORMULATIONS
DZ2947A1 (en) 1998-11-25 2004-03-15 Chiesi Farma Spa Pressure metered dose inhaler.
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
DE19921693A1 (en) 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Pharmaceutical composition for treating respiratory disorders, e.g. asthma, comprises combination of anticholinergic and beta-mimetic agents having synergistic bronchospasmolytic activity and reduced side-effects
DE19911064A1 (en) * 1999-03-12 2000-09-14 Ig Spruehtechnik Gmbh MDIs with isobutane as propellant
ES2165768B1 (en) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
IT1313553B1 (en) 1999-07-23 2002-09-09 Chiesi Farma Spa OPTIMIZED FORMULATIONS CONSTITUTED BY SOLUTIONS OF STEROIDS GIVEN BY INHALATION.
IT1313567B1 (en) * 1999-07-27 2002-09-09 Zambon Spa USE OF N-ACETYL-CISTEIN FOR THE PREPARATION OF TOPICAL PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ALLERGIC PATHOLOGIES OF
IT1317846B1 (en) 2000-02-22 2003-07-15 Chiesi Farma Spa FORMULATIONS CONTAINING AN ANTICOLINERGIC DRUG FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE BRONCOPNEUMOPATHY.
JP5392880B2 (en) 2000-05-22 2014-01-22 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ Stable pharmaceutical solution formulation for pressurized metered dose inhalers
DE10062712A1 (en) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma New drug compositions based on anticholinergics and corticosteroids
US7776315B2 (en) 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
AU2174102A (en) * 2000-10-31 2002-05-15 Boehringer Ingelheim Pharma Inhalative solution formulation containing a tiotropium salt
US20020137764A1 (en) 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
CA2436540C (en) * 2000-10-31 2008-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and corticosteroids
TR200401980T4 (en) 2001-07-02 2004-09-21 Chiesi Farmaceutici S.P.A. Tobramycin formulation optimized for aerosol administration
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
BRPI0407368A (en) * 2003-02-10 2006-02-14 Bayer Healthcare Ag treatment of bacterial diseases of the respiratory organs by local application and fluorquinolones.
AU2004246819A1 (en) 2003-06-13 2004-12-23 Nycomed Gmbh Formoterol and ciclesonide combination
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
PL2425820T3 (en) 2007-02-11 2015-08-31 Map Pharmaceuticals Inc Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
US8227027B2 (en) 2007-12-07 2012-07-24 Presspart Gmbh & Co. Kg Method for applying a polymer coating to an internal surface of a container
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
US8444873B2 (en) 2009-06-12 2013-05-21 Solvay Fluor Gmbh Refrigerant composition
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7708731A (en) * 1976-08-13 1978-02-15 Montedison Spa PROCESS FOR THE PREPARATION OF NEW DRIVER COMPOSITIONS FOR AEROSOLS.
SE8505048L (en) * 1985-10-25 1987-04-26 Nutritional Int Res Inst NUTRITION EMULSION WITH ACID TRANSPORTING PROPERTIES
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB8900267D0 (en) * 1989-01-06 1989-03-08 Riker Laboratories Inc Narcotic analgesic formulations and apparatus containing same
US5118494A (en) * 1990-03-23 1992-06-02 Minnesota Mining And Manufacturing Company Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU680967B2 (en) * 1993-12-20 1997-08-14 Minnesota Mining And Manufacturing Company Flunisolide aerosol formulations
US5776433A (en) * 1993-12-20 1998-07-07 Minnesota Mining And Manufacturing Company Flunisolide aerosol formulations

Also Published As

Publication number Publication date
NO920987D0 (en) 1992-03-13
ZA921877B (en) 1992-10-28
FI921060A (en) 1992-09-15
HU9200850D0 (en) 1992-05-28
KR920017643A (en) 1992-10-21
EP0504112A3 (en) 1993-04-21
MX9201082A (en) 1992-09-01
HUT60430A (en) 1992-09-28
NZ241938A (en) 1993-06-25
IE920826A1 (en) 1992-09-23
AU646723B2 (en) 1994-03-03
FI921060A0 (en) 1992-03-11
NO920987L (en) 1992-09-15
CA2062854A1 (en) 1992-09-15
JPH04327527A (en) 1992-11-17
IL101169A0 (en) 1992-11-15
EP0504112A2 (en) 1992-09-16
HU208398B (en) 1993-10-28

Similar Documents

Publication Publication Date Title
AU1218892A (en) Pharmaceutical aerosol formulations
AU4595689A (en) Medicinal aerosol formulations
AU2087992A (en) Pharmaceutical combination formulation
ZA914957B (en) Aerosol drug formulations
AU4341789A (en) Pharmaceutical formulations
ZA923272B (en) Pharmaceutical formulations
AU3716193A (en) Pharmaceutical compositions
GB9118830D0 (en) Medical aerosol formulations
ZA921093B (en) Pharmaceutical formulations
AU1189392A (en) Pharmaceutical agent
AU2392492A (en) Pharmaceutical composition
AU3949093A (en) A pharmaceutical formulation
GB9201639D0 (en) Pharmaceutical formulations
GB9311030D0 (en) Pharmaceutical formulations
GB9323399D0 (en) Pharmaceutical formulations
AU2493792A (en) Pharmaceutical preparation
AU2537992A (en) Pharmaceutical compositions
AU8996291A (en) Pharmaceutical formulations
AU6933794A (en) Pharmaceutical formulations
GB9204774D0 (en) Pharmaceutical formulations
GB9221244D0 (en) Pharmaceutical formulations
GB9307003D0 (en) Pharmaceutical formulations
GB9207338D0 (en) Pharmaceutical formulations
GB9203212D0 (en) Pharmaceutical formulations
GB9217602D0 (en) Pharmaceutical formulations